NOISESaved copy
Coverage history

Assembled by NOISE.

Saved report copy

Recorded

Viagra-like pill slows Alzheimer's in some trial patients

A low-dose version of the erectile dysfunction drug Mvix slowed mental decline by nearly a third over a year in early Alzheimer's patients not already taking other dementia medicines, about 40 percent of 1,500-plus trial participants. The benefit vanished in the other 60 percent, leaving the full-group result null, though sponsor AriBio says a prespecified win in either group met the study's goal. AriBio plans to ask the FDA whether the data stand alone or need another trial; if approved, it would be the first US pill authorized to slow Alzheimer's.